SEARCH RESULT

Total Matching Records found : 3409

Modi govt's flagship Atal Pension Yojana meets 10 per cent of target -Kumar Vikram

-India Today Concerned over the poor response, the Finance Ministry has asked all state-run banks to extend the date of government contribution till March 31, 2016. The Centre's flagship pension plan, launched with much fanfare last year, is struggling to stay afloat. It has been able to bring only about 10 per cent of the targeted two crore under its ambit. The Atal Pension Yojana (APY), aimed at ensuring pension for those...

More »

Discrimination on the campus -Sukhadeo Thorat

-The Hindu Even as the student population has become increasingly diverse, the high incidence of suicide among Dalit students points to continuing discrimination, exclusion and humiliation. There is a need to apply our minds in a calm manner to address the problems that Dalit students face in institutions of higher education and find a more durable solution, now that the University of Hyderabad has revoked the suspension of students in the context...

More »

How Do We Combat Droughts?

-Economic and Political Weekly Agriculture cannot be revived without a different approach to water, soil, crops and research. For the second year in succession, rainfall in the monsoon season has been less than normal. As many as 302 out of the 640 districts in the country have been declared drought-hit and the impact of the drought is the severest in nine major states of south, central and east India. It is striking...

More »

The new quota

-The Indian Express Bihar’s job reservation for women is a welcome gesture, but focus has to be on increasing opportunities and capabilities. The Bihar government’s move to reserve 35 per cent of all jobs in the state sector for women is an attempt to increase their presence in the workforce. However, with not many jobs being created in the public sector, the policy offers more symbolic value than radical content: Its...

More »

New diabetes drug cuts cost by 80%

-The Times of India MUMBAI: Diabetics in the country have something to cheer about. A completely new drug in the 'gliptin' family has disrupted the anti-diabetes market by lowering the cost of therapy for patients by 80%. With the launch of the teneligliptin molecule, the popular gliptin category has witnessed a price erosion of over 80% in the last six months, bringing down the cost for a day's treatment from Rs...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close